Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

$Thumbnail for Post-BCMA Sequencing in Relapsed/Refractory Multiple Myeloma: BCMA Re-Targeting Versus Non-BCMA T-Cell Redirection$

MM - 605

Post-BCMA Sequencing in Relapsed/Refractory Multiple Myeloma: BCMA Re-Targeting Versus Non-BCMA T-Cell Redirection

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

Thumbnail for Post-CAR-T Relapse in DLBCL: Real-World Salvage Therapy Patterns and Outcomes at a Tertiary Academic Center

ABCL - 865

Post-CAR-T Relapse in DLBCL: Real-World Salvage Therapy Patterns and Outcomes at a Tertiary Academic Center

Jivtesh Singh

Poster Presenter: Jivtesh Singh

Thumbnail for Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials

Previous 1...88 89 90 91 92 93 94...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

ALL - 1212

Post-Induction Consolidation With Blinatumomab vs Chemotherapy in First-Relapse B-Cell Acute Lymphoblastic Leukemia: Evidence From Randomized Controlled Trials

Bashar M Al Zoubi

Poster Presenter: Bashar M Al Zoubi

Thumbnail for Post-Transplant Oral Azacitidine Maintenance: Clinical Outcomes and Immune Landscape

AML - 739

Post-Transplant Oral Azacitidine Maintenance: Clinical Outcomes and Immune Landscape

Gabriela Sanchez-Petitto

Poster Presenter: Gabriela Sanchez-Petitto

Thumbnail for Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

AML - 867

Postmarketing Safety Signals of Revumenib (Menin-KMT2A Inhibitor) vs Acute Myeloid Leukemia-Targeted Therapies: A Class-Restricted Disproportionality Analysis of the FDA Adverse Event Monitoring System (2016-2026)

Arashdeep Singh

Poster Presenter: Arashdeep Singh

Thumbnail for Postransplant Cyclophosphamide Is Associated With Improved Long-Term Survival Following Second Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World Propensity Score-Matched Analysis

CT - 1349

Postransplant Cyclophosphamide Is Associated With Improved Long-Term Survival Following Second Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World Propensity Score-Matched Analysis

Muzammil Dastagir

Poster Presenter: Muzammil Dastagir

Thumbnail for Pre-CAR-T Antibiotic Exposure and Gut Microbiome Disruption as Predictors of Response and Survival in Hematologic Malignancies: A Systematic Review

CT - 497

Pre-CAR-T Antibiotic Exposure and Gut Microbiome Disruption as Predictors of Response and Survival in Hematologic Malignancies: A Systematic Review

Mary Anusha Chowdary Koka

Poster Presenter: Mary Anusha Chowdary Koka

Thumbnail for Precision Targeting of t(11; 14) Multiple Myeloma With Venetoclax: Evidence From a Systematic Review and Meta-Analysis

MM - 905

Precision Targeting of t(11; 14) Multiple Myeloma With Venetoclax: Evidence From a Systematic Review and Meta-Analysis

Sai Sree Gummadi

Poster Presenter: Sai Sree Gummadi

Thumbnail for Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

MPN - 553

Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

Liang-Chuan Wang

Poster Presenter: Liang-Chuan Wang

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.